Specific combinations of microbes living in our mouths have been associated with one of the deadliest cancers in humans, ...

(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...

A Cornell-led study has revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit speaks with PanCAN’s Chief Business Officer, Sudheer Doss, PhD, ...

New platform offers vital peer-to-peer support, shared experiences, and practical knowledge for those affected by pancreatic ...

Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU ...

Pancreatic cancer remains one of the deadliest cancers, with survival rates showing little improvement over decades and ...

Is our health system ready for multi-cancer detection tests? That was the question Fred Hutch's Dr. Scott Ramsey and others posed at a full-day Cancer Screening Intelligence for the Future symposium ...

Exploring the relationship between cancer cells and nerve cells, which can signal tumors to grow, could unearth ways to slow disease.

Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care ...

Akeso Inc. (9926.HK) has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), ...

Pancreatic cancer is one of the deadliest forms of cancer, with a five-year survival rate of only 13%. It is known for being ...